New York is currently home to 4503 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer
Recruiting
The purpose of the randomized control trial is to estimate the effect of an oncology clinical nurse specialist-led early intervention multidisciplinary approach to palliative and survivorship care within two previously identified and validated patient groups having metastatic solid tumor malignancy on patient-reported symptom burden, patient-reported overall quality of life (QOL), distress, and overall survival. The primary hypothesis is that the effect of an oncology clinical nurse specialist-... Read More
Gender:
ALL
Ages:
21 years and above
Trial Updated:
09/11/2023
Locations: Good Samaritan University Hospital, West Islip, New York
Conditions: Solid Tumor, Adult, Metastasis
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Recruiting
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
09/07/2023
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: NASH - Nonalcoholic Steatohepatitis
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Recruiting
stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
09/07/2023
Locations: MSKCC New York, New York, New York
Conditions: Ovarian Cancer
Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma
Recruiting
This clinical study is conducted to develop a new test to identify prostate cancer patients at highest risk of radiotherapy-related complications, especially related to gastrolintestinal (GI) toxicities. This clinical study would allow monitoring of total tissue damage in blood samples as early as after the 2nd but before the 4th radiotherapy dose during week 1 of radiotherapy, which could help clinicians make treatment decisions. Detection of excessive tissue damage at this early time, well bef... Read More
Gender:
MALE
Ages:
Between 30 years and 85 years
Trial Updated:
09/06/2023
Locations: NY Cancer and Blood Specialists, Bronx, New York
Conditions: Prostate Cancer
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Recruiting
The study is a Phase 1dose escalation study to evaluate the safety, tolerability, and pharmacokinetics of ASKG915 as a single agent in patients with selected advanced solid tumors.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/05/2023
Locations: Columbia University Irving Medical Center, New York, New York
Conditions: Advanced Solid Tumors
Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants
Recruiting
The goal of this clinical trial is to compare sleeping in a SNOO Smart Sleeper bassinet (SNOO) with sleeping in traditional bassinet conditions in premature infants. The main questions it aims to answer are: 1. Do preterm infants who sleep in the SNOO have more quiet sleep? 2. Do preterm infants who sleep in the SNOO have improved vital signs? * Participants will spend two separate three-hour periods sleeping in either a SNOO (which plays white noise and rocks from side-to-side) or in a SNO... Read More
Gender:
ALL
Ages:
Between 1 week and 12 weeks
Trial Updated:
09/05/2023
Locations: Morgan Stanley Children's Hospital Neonatal Intensive Care Unit, NewYork Presbyterian, New York, New York
Conditions: Prematurity, Very Preterm Maturity of Infant
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
Recruiting
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
09/01/2023
Locations: NY Scientific, Brooklyn, New York
Conditions: Ulcerative Colitis
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
Recruiting
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and t... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
08/31/2023
Locations: Oishei Children's Hospital University at Buffalo, Buffalo, New York
Conditions: Postpartum Hypertension
Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Pelvic Pain in Adults
Recruiting
TENS (transcutaneous electrical nerve stimulation) is accepted as a standard treatment for chronic pelvic pain, but the best settings to recommend, including frequency of stimulation, have not been defined to date. This study aims to find the optimal frequency, also known as cycles per second or Hertz (Hz) for treating chronic pelvic pain using non-invasive skin-level electrical nerve stimulation. The investigators will see how people respond to (20Hz, 50Hz or 100Hz). The study will have a two w... Read More
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
08/30/2023
Locations: Albany Medical Center, Albany, New York
Conditions: Chronic Pelvic Pain
IOP Elevation Study
Recruiting
The purpose of this study is to improve understanding of the pathophysiologic process that leads to the development of glaucamotous damage. The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased intraocular pressure (IOP) is a major risk factor. It is also thought that the LC is a site of primary damage during pathogenesis of the disease. This prospective study with determine the in-vivo mechanical response to IOP modulation at the level of the ONH... Read More
Gender:
ALL
Ages:
Between 18 years and 90 years
Trial Updated:
08/30/2023
Locations: NYU Langone Health, New York, New York
Conditions: Intraocular Pressure
Neurofibromatosis (NF) Registry Portal
Recruiting
The NF Registry is a database of patient-reported symptoms, treatments, and experiences with their neurofibromatosis disease. It is a contact registry to relay clinical trial opportunities to targeted patient subgroups, and to supply de-identified disease data to researchers. It has the potential to become a natural history resource.
Gender:
ALL
Ages:
All
Trial Updated:
08/29/2023
Locations: Children's Tumor Fundation, New York, New York
Conditions: Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis
Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)
Recruiting
Congenital heart defects (CHD) are the most common major human birth malformation, affecting \~8 per 1,000 live births. CHD are associated with significant morbidity and mortality, and are second only to infectious diseases in contributing to the infant mortality rate. Current understanding of the etiology of pediatric cardiovascular disorders is limited. The Congenital Heart Disease GEnetic NEtwork Study (CHD GENES) is a multi-center, prospective observational cohort study. Participants will b... Read More
Gender:
ALL
Ages:
99 years and below
Trial Updated:
08/29/2023
Locations: Cohen Children's Medical Center New York, New Hyde Park, New York
Conditions: Congenital Heart Defects